Due to pleocytosis in patients with early MS the absolute numbers of CD4+CD20+ T cells and CD8+CD20+ T cells were significantly higher in patients with early MS compared to symptomatic controls (p=0.0003 and p=0.001, respectively), Figure 2E. This evidence concerns the gene CD8A and myeloid sarcoma.